Cell and Gene Therapy Centre Opens in Stevenage

The Cell and Gene Therapy Catapult, a unique cell and gene therapy manufacturing centre designed by The Fairhursts Design Group, was officially opened on Monday morning by Business Secretary Greg Clark and Science Minister Sam Gyimah.

Backed by over £60 million of UK Government investment from its Industrial Strategy, the centre will support and develop the rapidly growing global cell and gene therapy industry in the United Kingdom whilst demonstrating the government’s modern Industrial Strategy in action.

“We are thrilled to open the Cell and Gene Therapy Catapult manufacturing centre with the Business Secretary Greg Clark and our initial collaborators Autolus, Cell Medica, AdaptImmune, Freeline,  and Thermo Fisher Scientific. These companies have international activities and choices, and have chosen to develop European-based manufacturing in the UK. The manufacturing centre is integral to the development of a thriving global cell and gene therapy industry. This is an area of medicine that has shown potential for decades and we now need new manufacturing technology like never before. The centre is a major statement of intent and a springboard for industry in its global development. The launch of this important facility pushes the agenda forward and accelerates the timeframe for bringing these living medicines to patients.”

Keith Thompson, Chief Executive Officer, CGT Catapult

For more information on the project, please visit our case study here.